Skip to content

A clinical trial of combination treatment with ketoconazole cream and adapalene in pityriasis versicolor

A clinical trial of combination treatment with ketoconazole cream and adapalene in pityriasis versicolor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003356
Enrollment
Unknown
Registered
2013-07-12
Start date
2011-11-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pityriasis versicolor

Interventions

1:topical ketoconazole cream and adapalene gel
2:topical ketoconazole cream

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 47 Years

Inclusion criteria

Inclusion criteria: (1) Patients must be males or females >=18 years old; (2) Patients must be diagnosed accurately and have typical symptoms with all hyperpigmentation rashes of pityriasis versicolor; (3) Patients must be able to communicate effectively with the study personnel; (4) Patients must be adequately informed of the nature and risks of the study and give written informed consent prior to screening.

Exclusion criteria

Exclusion criteria: (1) Patients who have a known hypersensitivity to ketoconazole cream or adapalene gel; (2) Patients who have received systemic or topical antimycotic agents within 1 month prior to enrollment in the study; (3) Patients who have other fungal infections, such as tinea pedias, tinea manus, tinea corporis, etc.; (4) Pregnant women or nursing mothers; (5) Patients with significant heart, renal or hepatic disease; (6) Patients who, in the opinion of the Investigator, have any other condition which renders the patient unable to complete the study.

Design outcomes

Primary

MeasureTime frame
microscopic fungal examination;scale;hyperpigmentation;pruritus;

Countries

China

Contacts

Public ContactJianbin Yu
doctoryu666@163.com+86 13938500592

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026